Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
31.78
-0.48 (-1.49%)
Jun 27, 2025, 4:00 PM - Market closed
Enovis Employees
Enovis had 7,367 employees as of December 31, 2024. The number of employees increased by 817 or 12.47% compared to the previous year.
Employees
7,367
Change (1Y)
817
Growth (1Y)
12.47%
Revenue / Employee
$291,868
Profits / Employee
-$109,877
Market Cap
1.82B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ENOV News
- 21 days ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor - GlobeNewsWire
- 6 weeks ago - Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Enovis Announces First Quarter 2025 Results - GlobeNewsWire
- 2 months ago - Enovis to Host First Quarter 2025 Results Conference Call on May 8th - GlobeNewsWire
- 3 months ago - Enovis Announces Appointment of Damien McDonald as Chief Executive Officer - GlobeNewsWire
- 3 months ago - Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 - GlobeNewsWire
- 4 months ago - Enovis Continues To Languish Despite Decent Financial Results - Seeking Alpha